I am proud to introduce you to Allergan plc (NYSE:AGN), a bold, global
pharmaceutical company and a leader in a new industry model – Growth Pharma. Our
world-class team of 16,000+ colleagues develops, manufactures and commercializes
innovative branded pharmaceuticals, devices, biologic and tissue products for
patients around the world. Fueled by our Open Science R&D model and one of the
broadest development pipelines in the industry, we are committed to innovation and
addressing unmet medical needs.
Allergan is also one of the world’s fastest growing pharmaceutical companies – and we
are committed to making it the best place to work and achieve career goals. Together,
we are carving new paths and taking bold, decisive actions that deliver results and
better outcomes for patients, providers, and colleagues. We are Allergan.
ALLERGAN:
A FOCUSED GROWTH PHARMA LEADER
A MESSAGE FROM BRENT SAUNDERS Allergan Chairman, President and CEO
CATEGORY LEADERSHIPMaintain/achieve # 1 & 2position in key therapeutic areas
Innovation driven to address unmet needs
STRONG TOP-LINE GROWTHSustainable top line revenue growth
Targeted geographic expansion
Leading global brands
CUSTOMERINTIMACYDeep knowledge of therapeutic area environment
Highly responsive/service oriented
Industry leading pipeline to sustaintherapeutic area growth and leadership
Development Powerhouse
GROWTHPHARMA
Simplified & reliable manufacturing network OPEN SCIENCE R&D
Sales and marketing engine
Industry leading operating margins
OPERATIONAL EXCELLENCE
SER-120Adult Nocturia
BotoxIndication X
Ceftazidime/AvibactamHABP/VABP
Aztreonam/AvibactamGram Neg Infect
UlipristalFibroids
EstradiolVaginal Cream VVA & Dyspareunia
M1 Agonist Alzheimer’s disease
M4 Agonist Alzheimer’s disease
M1/M4 AgonistAlzheimer's Disease
Donepezil-SolifenacinAlzheimer’s Disease
NMDA Part Co-Agonist Co-Agon Major Depression
Atogepant Migraine Prevention
ApimostinelMajor Depression
VraylarMultiple
SempranaAcute Migraine
BotoxMajor Depression
UbrogepantAcute Migraine
RapastinelMajor Depression
NR2Br AntagonistOCD/Autism
EvogliptinNASH
LinzessDelayed Release IBS-C
Relamorelin Diabetic Gastroparesis
FxR AgonistNASH
CenicrivirocNASH
BrazikumabUlcerative Colitis
BrazikumabCrohn’s Disease
SetipiprantAndrogenic Alopecia
Volbella Tear Trough
Aczone ComboAcne Vulgaris
Skin Quattro Device Delivery for Facial Fillers
HA ThreadsForehead & Neck
Larger Inspira TE Breast Augmentation
BoNT-A MT10109LAesthetics Facial Lines
LXR-B agonistAtopic Dermatitis
MicrocellBreast Augmentation
Phoenix Breast Augmentation
ROR-y T InhibitorMultiple (Psoriasis)
Latanoprost Lower Eyelid Fat
KybellaPeri-axilary Fat
BotoxPlatysma
VoLite Filler Fine Lines
Voluma Filler for Chin
Voluma Filler for Temple
Voluma Plus Facial Volumes
Voluma GlobalMalar Augmentation
Volift Nasolabial Folds
BotoxForehead Lines
SarecyclineAcne
Voluma Filler for Nose
Inspira TF2Breast Augmentation
EarfoldProminent Ears
BotoxMasseter
Botox Multiple
RituximabNon-Hodgkin Lymphoma
ArmourThyroidHypothyroidism
NeurostimAllergic Rhinitis
TrastuzumabMultiple Cancer
BevacizumabMultiple Cancer
Urology CNS Eye Care
Other(Biosimilars, Cardiovascular and other)
Gastro-enterology
2
13
26
172
2 7
6
Anti-Infective
Aesthetics & Dermatology
Women’s Health
AbiciparAMD
Bimatoprost SR Glaucoma
Chemokine AntagonistDry Eye
FPR2 AgonistDry Eye Disease
Pilo/Oxy Presbyopia
AbiciparDME
Brimo DDS Atrophic AMD
Cyclosporine SRDry Eye
Cortisol Analog Dry Eye Disease
Periocular RingGlaucoma/Other
Omega 3 OTC Dry Eye
Ganfort MDPF
DARPin® SR AMD
Optive Fusion China Dry Eye
Optive Fusion MDPF
REFRESH Artificial Tears
Optogenetic Gene Therapy Retinitis Pigmentosa
OUR OPEN SCIENCE
PIPELINEAllergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. We have leveraged this approach to build one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage programs in development. Learn more at Allergan.com.
17WOMEN’S
HEALTH
OUR GLOBAL FRANCHISES SPAN
7 THERAPEUTIC AREAS
USAFall River, MABranchburg, NJ Cincinnati, OHNorthern CA (Biologics)Irvine, CA (Biologics)Waco, TXJersey City, NJRockaway, NJBridgewater, NJIrvine, CA
COSTA RICASan Jose
BRAZILGuarulhos
IRELANDClonshaughWestportWestport
BELGIUMLiege
GERMANYWeiterstadt
FRANCEPringyPringy
MANUFACTURING
CHINABeijingShanghai
JAPANTokyo
UKLiverpoolMarlow
R&D
SINGAPORESingapore
NETWORK
OUR EXCEPTIONAL MANUFACTURING AND R&D
ANTI-INFECTIVES
CARDIOLOGY
EYE CARE
TM
(deoxycholic acid) injection 10 mg/mL
AESTHETICS, DERMATOLOGY &
REGENERATIVE MEDICINE
CENTRAL NERVOUS
SYSTEMUROLOGYGASTRO-
ENTEROLOGY
™
72 mcg •145 mcg • 290 mcg
We commit to these responsible pricing ideals for our branded therapeutics:
For more information, visit: www.Allergan.com/SocialContract
OUR SOCIAL CONTRACT WITH PATIENTS
We are committed to investing billions of dollars, at risk, to develop life-enhancing innovations.
1. INVEST & INNOVATE
2. ACCESS & PRICING
3. QUALITY & SAFETY We commit to intensely monitoring the safety of our medicines and promptly reporting and acting on new safety data. We also commit to maintaining high standards of quality while maintaining a continuous supply of our medicines.
4. EDUCATION We are committed to appropriately educating physicians about our medicines so that they can be used in the right patients for the right conditions.
These are our commitments to the medical professionals and patients who count on us to continue finding new treatments for their most pressing medical needs.
We commit to making these branded therapeutic treatments accessible and affordable to patients while also ensuring that we can continue to meet our “invest and innovate” obligations outlined in Principle 1.
U.S. ADMINISTRATIVE HEADQUARTERSMorris Corporate Center III • 400 Interpace ParkwayParsippany, NJ 07054 • USA
CORPORATE HEADQUARTERSClonshaugh Business & Technology ParkClonshaugh, Dublin D17 E400 • Ireland
Allergan® and its design are trademarks of Allergan, Inc. © 2017 Allergan. All rights reserved. www.Allergan.com • NYSE: AGN
Our Company’s success is powered by
our commitment to being Bold for Life.
Together, we are people of action.
Four actions describe how we work when
we’re at our best. They define our culture
and clarify what it means to live bold.
MEANS DOING WHAT IS RIGHTBOLD
BUILD BRIDGES
POWER IDEAS
DRIVE RESULTS
ACT FAST
We